132 related articles for article (PubMed ID: 6676924)
1. Assessment of disease activity in ulcerative colitis using indium-111-labelled leukocyte faecal excretion.
Saverymuttu SH; Peters AM; Hodgson HJ; Chadwick VS
Scand J Gastroenterol; 1983 Oct; 18(7):907-12. PubMed ID: 6676924
[TBL] [Abstract][Full Text] [Related]
2. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.
Røseth AG; Schmidt PN; Fagerhol MK
Scand J Gastroenterol; 1999 Jan; 34(1):50-4. PubMed ID: 10048733
[TBL] [Abstract][Full Text] [Related]
3. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease.
Saverymuttu SH; Peters AM; Lavender JP; Pepys MB; Hodgson HJ; Chadwick VS
Gastroenterology; 1983 Dec; 85(6):1333-9. PubMed ID: 6628930
[TBL] [Abstract][Full Text] [Related]
4. [111In-oxine marked leukocytes: a method for diagnosing the location and evaluating the activity of Crohn disease and ulcerative colitis].
Becker W; Fischbach W; Reiners C; Börner W
Z Gastroenterol; 1985 Oct; 23(10):557-64. PubMed ID: 3936291
[TBL] [Abstract][Full Text] [Related]
5. Clinical remission in Crohn's disease--assessment using faecal 111In granulocyte excretion.
Saverymuttu SH
Digestion; 1986; 33(2):74-9. PubMed ID: 3949092
[TBL] [Abstract][Full Text] [Related]
6. Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases.
Fischbach W; Becker W; Mössner J; Koch W; Reiners C
Gut; 1987 Apr; 28(4):386-93. PubMed ID: 3495470
[TBL] [Abstract][Full Text] [Related]
7. Indium-111-labeled autologous leukocyte imaging and fecal excretion. Comparison with conventional methods of assessment of inflammatory bowel disease.
Leddin DJ; Paterson WG; DaCosta LR; Dinda PK; Depew WT; Markotich J; McKaigney JP; Groll A; Beck IT
Dig Dis Sci; 1987 Apr; 32(4):377-87. PubMed ID: 3829880
[TBL] [Abstract][Full Text] [Related]
8. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion.
Saverymuttu SH; Camilleri M; Rees H; Lavender JP; Hodgson HJ; Chadwick VS
Gastroenterology; 1986 May; 90(5 Pt 1):1121-8. PubMed ID: 3956932
[TBL] [Abstract][Full Text] [Related]
9. 111Indium autologous granulocytes in the detection of inflammatory bowel disease.
Saverymuttu SH; Peters AM; Crofton ME; Rees H; Lavender JP; Hodgson HJ; Chadwick VS
Gut; 1985 Sep; 26(9):955-60. PubMed ID: 4029721
[TBL] [Abstract][Full Text] [Related]
10. Location and activity of ulcerative and Crohn's colitis by indium 111 leukocyte scan. A prospective comparison study.
Stein DT; Gray GM; Gregory PB; Anderson M; Goodwin DA; McDougall IR
Gastroenterology; 1983 Feb; 84(2):388-93. PubMed ID: 6848412
[TBL] [Abstract][Full Text] [Related]
11. [111In-oxine-labeled granulocytes in Crohn disease and ulcerative colitis. Labeling and study technics].
Becker W; Fischbach W; Reiners C; Börner W
Rofo; 1985 Mar; 142(3):320-5. PubMed ID: 2984737
[TBL] [Abstract][Full Text] [Related]
12. 111Indium autologous leucocytes in inflammatory bowel disease.
Saverymuttu SH; Peters AM; Lavender JP; Hodgson HJ; Chadwick VS
Gut; 1983 Apr; 24(4):293-9. PubMed ID: 6832626
[TBL] [Abstract][Full Text] [Related]
13. Differing acute phase responses in Crohn's disease and ulcerative colitis.
Saverymuttu SH; Hodgson HJ; Chadwick VS; Pepys MB
Gut; 1986 Jul; 27(7):809-13. PubMed ID: 3732890
[TBL] [Abstract][Full Text] [Related]
14. Comparison of fecal granulocyte excretion in ulcerative colitis and Crohn's colitis.
Saverymuttu SH; Hodgson HJ; Chadwick VS
Dig Dis Sci; 1984 Nov; 29(11):1000-4. PubMed ID: 6489079
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte migration in ulcerative colitis.
Saverymuttu SH; Chadwick VS; Hodgson HJ
Eur J Clin Invest; 1985 Apr; 15(2):60-3. PubMed ID: 3922769
[TBL] [Abstract][Full Text] [Related]
16. Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease?
Crama-Bohbouth G; Pena AS; Biemond I; Verspaget HW; Blok D; Arndt JW; Weterman IT; Pauwels EK; Lamers CB
Gut; 1989 Sep; 30(9):1236-40. PubMed ID: 2806991
[TBL] [Abstract][Full Text] [Related]
17. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein.
Røseth AG; Aadland E; Jahnsen J; Raknerud N
Digestion; 1997; 58(2):176-80. PubMed ID: 9144308
[TBL] [Abstract][Full Text] [Related]
18. Assessment of disease activity in inflammatory bowel disease: a new approach using 111In granulocyte scanning.
Saverymuttu SH; Lavender JP; Hodgson HJ; Chadwick VS
Br Med J (Clin Res Ed); 1983 Dec; 287(6407):1751-3. PubMed ID: 6416576
[TBL] [Abstract][Full Text] [Related]
19. Specificity of indium-111 granulocyte scanning and fecal excretion measurement in inflammatory bowel disease--an autoradiographic study.
Keshavarzian A; Price YE; Peters AM; Lavender JP; Wright NA; Hodgson HJ
Dig Dis Sci; 1985 Dec; 30(12):1156-60. PubMed ID: 4064866
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of activity parameters in Crohn's disease estimated by the faecal excretion of 111In-labeled granulocytes.
Fischbach W; Becker W
Digestion; 1991; 50(3-4):149-52. PubMed ID: 1812041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
